The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
This randomized multicenter, open-label, trial compared efficacy, acceptability, tolerability and compliance of NuvaRing with a combined oral contraceptive (COC), containing 30 μg of ethinyl estradiol (EE) and 3 mg of drospirenone.In this 13-cycle study, 983 women were randomized and treated (intent-to-treat population) with NuvaRing or COC.One in-treatment pregnancy occurred with NuvaRing (Pearl...
This open-label, randomized, Phase III study compared the efficacy and tolerability of and compliance with NuvaRing, a combined contraceptive vaginal ring releasing 15 μg of ethinylestradiol (EE) and 120 μg of etonogestrel daily, with those of and with a combined oral contraceptive (COC) containing 150 μg of levonorgestrel (LNG) and 30 μg of EE. Subjects received NuvaRing or a COC for 13 cycles (3...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.